| Entry |
|
|---|
| Name |
Pemvidutide (USAN/INN) |
|---|
| Formula |
C182H275N39O54
|
|---|
| Exact mass |
3870.9972
|
|---|
| Mol weight |
3873.36
|
|---|
| Structure |
 |
|---|
| Sequence |
HXQGTFTSDY SKYLDEKAAK EFIQWLLQT |
|---|
| Type |
Peptide |
|---|
| Class |
Antidiabetic agent
DG02044 Hypoglycemic agent
DG01493 GLP-1 receptor agonist
Unclassified
DG03355 Oxyntomodulin analog
|
|---|
| Efficacy |
Antiobesity, Glucagon-like peptide 1 (GLP-1) receptor agonist, Glucagon receptor agonist |
|---|
| Type |
Modified peptide |
|---|
| Comment |
Treatment of non-alcoholic steatohepatitis (NASH) and obesity
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Antidiabetic agent
DG02044 Hypoglycemic agent
DG01493 GLP-1 receptor agonist
D12861 Pemvidutide
Unclassified
DG03355 Oxyntomodulin analog
D12861 Pemvidutide
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Secretin receptor family
Glucagon
GLP1R
D12861 Pemvidutide (USAN/INN)
GCGR
D12861 Pemvidutide (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
